COMMUNIQUÉS West-GlobeNewswire
-
EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
02/03/2018 - 22:28 -
Clearside Biomedical Schedules Conference Call to Review Topline Results from Pivotal Phase 3 PEACHTREE Clinical Trial of CLS-TA in Macular Edema Associated with Non-Infectious Uveitis
02/03/2018 - 22:05 -
Recro Pharma Announces Commercial Team Additions
02/03/2018 - 22:05 -
Endocyte Announces Closing of Public Offering of Common Stock
02/03/2018 - 22:01 -
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
02/03/2018 - 22:01 -
Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2017
02/03/2018 - 22:01 -
The Delta Companies Chairman Seiki “Stan” Hirota Named to the Prestigious Staffing 100 List by Staffing Industry Analysts
02/03/2018 - 21:26 -
Celldex to Report Fourth Quarter and Year-End 2017 Business/Financial Results and Present at Upcoming Investor Conference
02/03/2018 - 21:15 -
Tauriga Sciences Inc. to Issue Important and Material Shareholder Update Early Next Week
02/03/2018 - 21:00 -
ICU Medical, Inc. to Present at Raymond James’ 39th Annual Institutional Investors Conference
02/03/2018 - 18:51 -
RavenQuest Expands National Presence; Completes Bloomera Acquisition
02/03/2018 - 18:00 -
Otonomy Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa
02/03/2018 - 17:55 -
Tauriga Sciences Inc. Acquires Equity Stake in Colorado based NASDAQ Listed Biotechnology Firm Focused in the Medical Field of Urology
02/03/2018 - 17:35 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
02/03/2018 - 17:31 -
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
02/03/2018 - 16:49 -
ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
02/03/2018 - 15:15 -
HIMSS Analytics Honors Pagosa Springs Medical Center with Stage 7 Recognition
02/03/2018 - 15:01 -
Patient Home Monitoring Releases First Quarter Financial Results
02/03/2018 - 15:00 -
RavenQuest Completes Financings for $24.5 Million
02/03/2018 - 15:00
Pages